Preventing blood clots in cancer patients with catheter-related clots
Treatments studied
Part of Cancer, Heart & circulation, Infections clinical trials.
This study tests whether a lower dose of the blood thinner apixaban (Eliquis) can safely prevent another blood clot in people with cancer who have a catheter-related clot in their upper arm or neck. It aims to find a balance between preventing clots and reducing bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have active cancer (diagnosed or treated in the last 6 months, or cancer that has spread).
- You have a confirmed blood clot in your upper arm or neck from a catheter and have been on blood thinners for at least 3 months.
- You are not currently bleeding or at high risk of bleeding.
- You do not need blood thinners for another condition like atrial fibrillation or a mechanical heart valve.
- You are not allergic to apixaban (Eliquis) and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different ways to take the blood thinner apixaban to prevent blood clots in people with cancer who are starting or switching their cancer treatment. It aims to find the best dose for safety and effectiveness.
This study tests whether the blood thinner edoxaban can safely prevent blood clots caused by a central venous catheter in cancer patients. It may be an option if you have a catheter and are not already on blood thinners.
This Phase 3 study tests whether the medicine rivaroxaban can prevent dangerous blood clots in people with cancer who have a central venous catheter placed recently. It may help reduce clot risk while your catheter is in place, but you must meet safety and bleeding-risk criteria.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.